Article
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Neutral
0.0
−100 Bearish
0
+100 Bullish
It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This